Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Autoimmune Treatment Global Market Report 2025
Request Sample Buy Now
Global Autoimmune Treatment Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Autoimmune Treatment Global Market Report 2025

By Product (Consumables and Assay Kits, Instruments, Services), By Service Type (Consultation and Diagnosis, Therapy and monitoring, Drug development), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases), By Drug Class (Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class), By End User (Clinical Laboratories, Hospitals, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Autoimmune Treatment Market Overview

• Autoimmune Treatment market size has reached to $7.72 billion in 2024

• Expected to grow to $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%

• Growth Driver: Research And Development Investments Accelerate Growth In The Autoimmune Treatment Market

• Market Trend: Technological Advancements Drive Innovation In Autoimmune Treatment Market

• North America was the largest region in 2024.

What Is Covered Under Autoimmune Treatment Market?

Autoimmune treatment refers to the management and care of a patient for the purpose of combating an autoimmune disease or disorder. This is a type of condition in which one's immune system starts attacking its own body cells. The autoimmune treatment is used to treat autoimmune diseases.

The main types of products in autoimmune treatment are consumables and assay kits, instruments, and services. Consultation refers to seeking assistance from another physicians or health care professionals for diagnostic studies, therapeutic interventions, or other services. Diagnosis is the process of identifying the nature of an illness or other problem by examination of the signs and symptoms. The main service types include consultation and diagnosis, therapy and monitoring, and drug development that involve several diseases such as rheumatoid arthritis, systemic lupus erythematosus, sjögren’s syndrome, thyroiditis, scleroderma, and others. The main drug classes include anti-inflammatory, anti-hyperglycemics, NSAIDs, interferons, and others. The main end user are clinical laboratories, hospitals, and others.

Autoimmune Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Autoimmune Treatment Market Size 2025 And Growth Rate?

The autoimmune treatment market size has grown rapidly in recent years. It will grow from $7.72 billion in 2024 to $8.63 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing prevalence, advancements in immunology, genetic research insights, patient awareness and advocacy, regulatory support.

What Is The Autoimmune Treatment Market Growth Forecast?

The autoimmune treatment market size is expected to see rapid growth in the next few years. It will grow to $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to precision medicine approaches, emergence of small molecule therapies, targeting novel pathways, gene therapy innovations, increasing biopharmaceutical investments, biosimilar market growth. Major trends in the forecast period include advancements in biologics and targeted therapies, immunomodulatory therapies, focus on rare autoimmune diseases, telemedicine and remote monitoring, regulatory initiatives and drug approvals, integration of digital health tools.

The forecast of 13.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. immunology care by restricting access to JAK inhibitors and IVIG therapies imported from Ireland and Denmark, potentially worsening disease control and increasing specialty pharmacy costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Autoimmune Treatment Market Segmented?

1) By Product: Consumables And Assay Kits, Instruments, Services

2) By Service Type: Consultation And Diagnosis, Therapy And monitoring, Drug development

3) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

4) By Drug Class: Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class

Subsegments:

1) By Consumables And Assay Kits: ELISA Kits, Reagents And Antibodies, Sample Collection Kits

2) By Instruments: Diagnostic Equipment, Imaging Systems

3) By Services: Testing And Diagnostics Services, Consultation And Support Services, Data Analysis And Interpretation Services

What Is Driving The Autoimmune Treatment Market? Research And Development Investments Accelerate Growth In The Autoimmune Treatment Market

The increase in investments in research and development of drugs for autoimmune diseases are expected to propel the growth of the autoimmune treatment market going forward. Research and development are the actions businesses take to innovate and launch new goods and services. Research and development of drugs for autoimmune diseases allows for the development of more targeted, low-molecular-weight, orally active, and chemically characterized immune suppressive drugs with acceptable tolerability in the context of long-term autoimmune disease treatment. For instance, in January 2022, Eli Lilly and Company, a US-based pharmaceutical company, increased its R&D investment from $7 billion in 2021 to $7.19 billion in 2022, resulting in an increase in its R&D spend as a percentage of revenue from 24.8% to 25.19%. Therefore, the increasing investments in research and development of drugs drives the autoimmune treatment industry growth.

What Is Driving The Autoimmune Treatment Market? Increasing Healthcare Expenditures Boosting The Autoimmune Treatment Market

The rise in healthcare expenditures is expected to propel the growth of the autoimmune treatment market going forward. Health expenditures refer to all costs associated with providing health services, family planning activities, nutrition programs, and emergency help with a focus on health. A rise in healthcare expenditure would result in the development of more effective therapies and medical technologies for autoimmune treatment. For instance, according to the economic forecast from the Office for Budget Responsibility (OBR) and Treasury, the UK's planned health expenditure is projected to increase to £192 billion ($244.43 billion) in 2024/25, up from £182 billion ($231.70 billion) in 2022/23. Similarly, the National Health Expenditures Accounts (NHEA) from KFF, a US-based independent health policy research organization, indicate that health spending in the United States is anticipated to grow by 5% from 2023 to 2024, reaching $4.9 trillion. Therefore, the rise in healthcare expenditures is driving the growth of the autoimmune treatment industry.

Who Are The Major Players In The Global Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.

What Are The Key Trends Of The Global Autoimmune Treatment Market? Technological Advancements Drive Innovation In Autoimmune Treatment Market

Technological advancements are a key trend gaining popularity in the autoimmune treatment market. Major companies operating in the market are developing advanced technologies to sustain their position in the market. For instance, in June 2023, UCB, a Belgium-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for RYSTIGGO (rozanolixizumab-noli) in the treatment of generalized myasthenia gravis (gMG) in adults who test positive for anti-acetylcholine receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies, with the approval being expedited under Priority Review. RYSTIGGO stands as the exclusive FDA-approved therapy for both anti-AchR and anti-MuSK antibody-positive gMG, encompassing the two most prevalent subtypes of this condition diagnosis of autoimmune illnesses, which might improve provider efficiency, increase the efficacy of treatment, and improve patient care.

What Are The Key Trends Of The Global Autoimmune Treatment Market? Innovative Clinical Trial Platforms Transform Autoimmune Treatment Market

Major companies operating in the autoimmune treatment market are increasing their focus on introducing innovative clinical trial platforms to gain a competitive edge in the market. Innovative clinical trial platforms in autoimmune treatment leverage advanced technologies and personalized approaches to enhance efficacy, safety, and patient outcomes. For instance, in August 2023, the Scleroderma Research Foundation, a US-based non-profit organization, launched the CONQUEST trial platform. The CONQUEST program aims to advance research and treatments for scleroderma, a rare autoimmune disease that affects connective tissues. It address critical issues in clinical development and enable advances in scleroderma therapeutics. The CONQUEST platform clinical trial is the first of its kind in rare autoimmune diseases, and it is designed to quickly evaluate potential treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD) as well as global SSc outcomes, including some focused on skin and other aspects of the disease.

Need data on a specific region in this market?
Request Customisation

Autoimmune Treatment Market Merger And Acquisition: Eli Lilly's Acquisition Expands Immunology Portfolio With Dice Therapeutics

In August 2023, Eli Lilly and Company, a US-based pharmaceutical company, acquired DICE Therapeutics, Inc. for $2.4 billion. The acquisition broadens Lilly's immunology product range by incorporating DICE's innovative oral therapeutic candidates, including oral IL-17 inhibitors currently undergoing clinical development for the treatment of chronic immunological disorders. DICE Therapeutics, Inc. is a US-based pharmaceutical company that focuses on developing novel oral therapies for autoimmune and inflammatory conditions.

Regional Outlook For The Global Autoimmune Treatment Market

North America was the largest region in the autoimmune treatment market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Autoimmune Treatment Market?

The autoimmune treatment includes revenues earned by entities by providing immunosuppressive therapy, biological treatment, immuno-suppressing medications services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Autoimmune Treatment Industry?

The autoimmune treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the autoimmune treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Autoimmune Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $8.63 billion
Revenue Forecast In 2034 $14.54 billion
Growth Rate CAGR of 13.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Consumables And Assay Kits, Instruments, Services
2) By Service Type: Consultation And Diagnosis, Therapy And monitoring, Drug development
3) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases
4) By Drug Class: Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class Subsegments: 1) By Consumables And Assay Kits: ELISA Kits, Reagents And Antibodies, Sample Collection Kits
2) By Instruments: Diagnostic Equipment, Imaging Systems
3) By Services: Testing And Diagnostics Services, Consultation And Support Services, Data Analysis And Interpretation Services
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Autoimmune Treatment Market Characteristics

3. Autoimmune Treatment Market Trends And Strategies

4. Autoimmune Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Autoimmune Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Autoimmune Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Autoimmune Treatment Market Growth Rate Analysis

5.4. Global Autoimmune Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Autoimmune Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Autoimmune Treatment Total Addressable Market (TAM)

6. Autoimmune Treatment Market Segmentation

6.1. Global Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consumables and Assay Kits

Instruments

Services

6.2. Global Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consultation and Diagnosis

Therapy and monitoring

Drug development

6.3. Global Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rheumatoid Arthritis

Systemic Lupus Erythematosus

Sjögren’s Syndrome

Thyroiditis

Scleroderma

Other Diseases

6.4. Global Autoimmune Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anti-Inflammatory

Anti-Hyperglycemic

NSAIDs

Interferons

Other Drug Class

6.5. Global Autoimmune Treatment Market, Sub-Segmentation Of Consumables And Assay Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

ELISA Kits

Reagents And Antibodies

Sample Collection Kits

6.6. Global Autoimmune Treatment Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Equipment

Imaging Systems

6.7. Global Autoimmune Treatment Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Testing And Diagnostics Services

Consultation And Support Services

Data Analysis And Interpretation Services

7. Autoimmune Treatment Market Regional And Country Analysis

7.1. Global Autoimmune Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Autoimmune Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autoimmune Treatment Market

8.1. Asia-Pacific Autoimmune Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autoimmune Treatment Market

9.1. China Autoimmune Treatment Market Overview

9.2. China Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autoimmune Treatment Market

10.1. India Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autoimmune Treatment Market

11.1. Japan Autoimmune Treatment Market Overview

11.2. Japan Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autoimmune Treatment Market

12.1. Australia Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autoimmune Treatment Market

13.1. Indonesia Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autoimmune Treatment Market

14.1. South Korea Autoimmune Treatment Market Overview

14.2. South Korea Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autoimmune Treatment Market

15.1. Western Europe Autoimmune Treatment Market Overview

15.2. Western Europe Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autoimmune Treatment Market

16.1. UK Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autoimmune Treatment Market

17.1. Germany Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autoimmune Treatment Market

18.1. France Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autoimmune Treatment Market

19.1. Italy Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autoimmune Treatment Market

20.1. Spain Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autoimmune Treatment Market

21.1. Eastern Europe Autoimmune Treatment Market Overview

21.2. Eastern Europe Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autoimmune Treatment Market

22.1. Russia Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autoimmune Treatment Market

23.1. North America Autoimmune Treatment Market Overview

23.2. North America Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autoimmune Treatment Market

24.1. USA Autoimmune Treatment Market Overview

24.2. USA Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autoimmune Treatment Market

25.1. Canada Autoimmune Treatment Market Overview

25.2. Canada Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autoimmune Treatment Market

26.1. South America Autoimmune Treatment Market Overview

26.2. South America Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autoimmune Treatment Market

27.1. Brazil Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autoimmune Treatment Market

28.1. Middle East Autoimmune Treatment Market Overview

28.2. Middle East Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autoimmune Treatment Market

29.1. Africa Autoimmune Treatment Market Overview

29.2. Africa Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autoimmune Treatment Market Competitive Landscape And Company Profiles

30.1. Autoimmune Treatment Market Competitive Landscape

30.2. Autoimmune Treatment Market Company Profiles

30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Autoimmune Treatment Market Other Major And Innovative Companies

31.1. Hoffmann-La Roche AG

31.2. AstraZeneca PLC

31.3. Bristol-Myers Squibb Company

31.4. Autoimmune Inc.

31.5. Siemens Healthcare Private Limited

31.6. Thermo Fisher Scientific Inc.

31.7. Biogen Idec Inc.

31.8. Bayer Schering Pharma AG

31.9. GSK PLC

31.10. Genentech Inc.

31.11. AbbVie Inc.

31.12. Celgene Corporation

31.13. Gilead Sciences Inc.

31.14. Merck & Co. Inc.

31.15. Novartis International AG

32. Global Autoimmune Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autoimmune Treatment Market

34. Recent Developments In The Autoimmune Treatment Market

35. Autoimmune Treatment Market High Potential Countries, Segments and Strategies

35.1 Autoimmune Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Autoimmune Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Autoimmune Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

Need tailored insights? Customise this report to fit your business goals.

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Autoimmune Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Autoimmune Treatment Market, Sub-Segmentation Of Consumables And Assay Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Autoimmune Treatment Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Autoimmune Treatment Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Autoimmune Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Autoimmune Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Abbott Laboratories Financial Performance
  • Table 79: Amgen Inc. Financial Performance
  • Table 80: Johnson & Johnson Services Inc. Financial Performance
  • Table 81: Eli Lilly and Company Financial Performance
  • Table 82: Pfizer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Autoimmune Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Autoimmune Treatment Market, Sub-Segmentation Of Consumables And Assay Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Autoimmune Treatment Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Autoimmune Treatment Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Autoimmune Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Autoimmune Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Abbott Laboratories Financial Performance
  • Figure 79: Amgen Inc. Financial Performance
  • Figure 80: Johnson & Johnson Services Inc. Financial Performance
  • Figure 81: Eli Lilly and Company Financial Performance
  • Figure 82: Pfizer Inc. Financial Performance

Global Artificial Intelligence in Medical Imaging Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global Artificial Intelligence in Medical Imaging Market Trends: Regional Breakdowns and Strategic Insights

Artificial Intelligence In Medicine Outlook 2034: Key Drivers, Trends, and Market Frontiers

Read More About Artificial Intelligence In Medicine Outlook 2034: Key Drivers, Trends, and Market Frontiers

Artificial Intelligence In OncologyMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

Read More About Artificial Intelligence In OncologyMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

From Insight to Impact: Strategic Growth Mapping in the Artificial Intelligence In Radiology Market

Read More About From Insight to Impact: Strategic Growth Mapping in the Artificial Intelligence In Radiology Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodie...

View Report

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2025 – By Product (Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants), By Procedure Type (Tr...

View Report

Fertility Treatments Global Market Report 2025 – By Product (Reagents, Equipment), By Patient Type (Female, Male), By End-User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes) – Impact of Ta...

View Report

Polycystic Ovarian Syndrome Treatment Global Market Report 2025 – By Drug Type (Oral Contraceptives, Ornithine Decarboxylase Inhibitors, Insulin-Sensitizing Agents, Anti-Depressants, Diuretics, Aromatase Inhibitors), By ...

View Report

Neutropenia Biologic Drug Treatment Global Market Report 2025 – By Drug Type (Filgrastim, Pegfilgrastim, Lenograstim, Lipegfilgrastim, Sargramostim), By Treatment Type (Antibiotic Drugs, Granulocyte-Colony-Stimulating Fa...

View Report

Psoriatic Arthritis Treatment Global Market Report 2025 – By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes), By Route Of Adminis...

View Report

Frequently Asked Questions

Autoimmune treatment refers to the management and care of a patient for the purpose of combating an autoimmune disease or disorder. This is a type of condition in which one's immune system starts attacking its own body cells. The autoimmune treatment is used to treat autoimmune diseases. For further insights on this market, request a sample here

The market major growth driver - Research And Development Investments Accelerate Growth In The Autoimmune Treatment Market. For further insights on this market, request a sample here

The autoimmune treatment market size has grown rapidly in recent years. It will grow from $7.72 billion in 2024 to $8.63 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing prevalence, advancements in immunology, genetic research insights, patient awareness and advocacy, regulatory support. The autoimmune treatment market size is expected to see rapid growth in the next few years. It will grow to " $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to precision medicine approaches, emergence of small molecule therapies, targeting novel pathways, gene therapy innovations, increasing biopharmaceutical investments, biosimilar market growth. Major trends in the forecast period include advancements in biologics and targeted therapies, immunomodulatory therapies, focus on rare autoimmune diseases, telemedicine and remote monitoring, regulatory initiatives and drug approvals, integration of digital health tools. For further insights on this market, request a sample here

The autoimmune treatmentmarket covered in this report is segmented –
1) By Product: Consumables And Assay Kits; Instruments; Services
2) By Service Type: Consultation And Diagnosis; Therapy And monitoring; Drug development
3) By Disease: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Sjögren’s Syndrome; Thyroiditis; Scleroderma; Other Diseases
4) By Drug Class: Anti-Inflammatory; Anti-Hyperglycemic; NSAIDs; Interferons; Other Drug Class Subsegments:
1) By Consumables And Assay Kits: ELISA Kits; Reagents And Antibodies; Sample Collection Kits
2) By Instruments: Diagnostic Equipment; Imaging Systems
3) By Services: Testing And Diagnostics Services; Consultation And Support Services; Data Analysis And Interpretation Services For further insights on this market, request a sample here

North America was the largest region in the autoimmune treatment market in 2024. The regions covered in the autoimmune treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc. . For further insights on this market, request a sample here.

Major trends in this market include Technological Advancements Drive Innovation In Autoimmune Treatment Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Autoimmune Treatment Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top
\
Back to top